This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Systemix, Inc.. Active years: 1999-2000.
Company Filing History:
Years Active: 1999-2000
Title: Ernst Bohnlein: Innovator in Retroviral Technology
Introduction
Ernst Bohnlein is a notable inventor based in Los Altos, CA (US). He has made significant contributions to the field of retroviral technology, holding 2 patents that focus on methods for producing retroviral packaging cell lines.
Latest Patents
His latest patents include a method for obtaining retroviral packaging cell lines capable of producing high-quality retroviral vectors. This invention provides a method for obtaining a recombinant retroviral packaging cell that can produce retroviral vectors. Additionally, it describes a method for producing recombinant retroviral particles by introducing a recombinant retroviral vector into the packaging cells and propagating the resulting producer cells under conditions favorable for the production and secretion of retroviral vector supernatant. The retroviral supernatants produced by these methods are also claimed. Furthermore, this invention offers a method for screening retroviral vector supernatant for high transduction efficiency, which is crucial for gene therapy applications.
Career Highlights
Ernst Bohnlein has had a distinguished career, working at Systemix, Inc., where he has been able to apply his innovative ideas in a practical setting. His work has contributed to advancements in gene therapy and retroviral research.
Collaborations
He has collaborated with notable colleagues such as Richard J Rigg and Jingyi Chen, further enhancing the impact of his work in the field.
Conclusion
Ernst Bohnlein's contributions to retroviral technology and gene therapy are significant, showcasing his expertise and innovative spirit. His patents reflect a commitment to advancing medical science and improving therapeutic techniques.